$148 Million is the total value of DCF Advisers, LLC's 67 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PSFE | Exit | PAYSAFE LIMITEDord | $0 | – | -16,760 | -100.0% | -0.02% | – |
| TLT | Exit | ISHARES TRcall | $0 | – | -2,000 | -100.0% | -0.13% | – |
| GAM | Exit | GENERAL AMERN INVS CO INC | $0 | – | -6,250 | -100.0% | -0.14% | – |
| INTC | Exit | INTEL CORP | $0 | – | -10,000 | -100.0% | -0.17% | – |
| EOG | Exit | EOG RES INC | $0 | – | -3,000 | -100.0% | -0.22% | – |
| GLD | Exit | SPDR GOLD TRcall | $0 | – | -2,500 | -100.0% | -0.25% | – |
| FXY | Exit | INVESCO CURRENCYSHARES JAPANjapanese yen | $0 | – | -6,750 | -100.0% | -0.28% | – |
| KWEB | Exit | KRANESHARES TRcsi chi internet | $0 | – | -22,500 | -100.0% | -0.36% | – |
| MU | Exit | MICRON TECHNOLOGY INCput | $0 | – | -11,500 | -100.0% | -0.37% | – |
| FXY | Exit | INVESCO CURRENCYSHARES JAPANput | $0 | – | -10,000 | -100.0% | -0.42% | – |
| INTC | Exit | INTEL CORPcall | $0 | – | -27,500 | -100.0% | -0.46% | – |
| HYG | Exit | ISHARES TRiboxx hi yd etf | $0 | – | -17,500 | -100.0% | -0.81% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -10,000 | -100.0% | -1.06% | – |
| PRTA | Exit | PROTHENA CORP PLCput | $0 | – | -27,500 | -100.0% | -1.08% | – |
| AAPL | Exit | APPLE INCput | $0 | – | -15,000 | -100.0% | -1.34% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -157,665 | -100.0% | -1.54% | – |
| GDX | Exit | VANECK VECTORS ETF TRgold miners etf | $0 | – | -102,500 | -100.0% | -1.60% | – |
| PRTA | Exit | PROTHENA CORP PLCcall | $0 | – | -52,500 | -100.0% | -2.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.